Securities Class Action

Securities fraud litigation history and active cases

In Litigation

1

Settlement

0

Closed

0

Total Settlement

$0

Eiger BioPharmaceuticals, Inc. (EIGR) Class Action Lawsuit (November 2022)

In Litigation

3:22cv6985 • November 8, 2022

Class Period Start

March 10, 2021

Class Period End

October 4, 2022

PSLRA Deadline

January 9, 2023

Case Allegations

10b5

Statutes of Repose

Mar 10, 2024

Country

United States

Court

Federal Court

Docket History

Apr 10, 2023

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Feb 3, 2023

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Nov 8, 2022

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in Eiger BioPharmaceuticals, Inc..